Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Stem Cells International
Volume 2016, Article ID 9762465, 7 pages
http://dx.doi.org/10.1155/2016/9762465
Review Article

Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells

1Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 330-714, Republic of Korea
2Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 330-714, Republic of Korea

Received 27 November 2015; Accepted 28 January 2016

Academic Editor: Boon C. Heng

Copyright © 2016 Jung-Hwan Lee and Seog-Jin Seo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Okano and S. Yamanaka, “iPS cell technologies: significance and applications to CNS regeneration and disease,” Molecular Brain, vol. 7, article 22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Yamanaka, “Induced pluripotent stem cells: past, present, and future,” Cell Stem Cell, vol. 10, no. 6, pp. 678–684, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kriks, J.-W. Shim, J. Piao et al., “Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease,” Nature, vol. 480, no. 7378, pp. 547–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Takayama, S. Nishimura, S. Nakamura et al., “Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells,” The Journal of Experimental Medicine, vol. 207, no. 13, pp. 2817–2830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Nori, Y. Okada, A. Yasuda et al., “Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 40, pp. 16825–16830, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Okamoto and M. Takahashi, “Induction of retinal pigment epithelial cells from monkey iPS cells,” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 8785–8790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Kunisada, N. Tsubooka-Yamazoe, M. Shoji, and M. Hosoya, “Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells,” Stem Cell Research, vol. 8, no. 2, pp. 274–284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Yan, H. Qin, C. Qu, R. S. Tuan, S. Shi, and G. T.-J. Huang, “iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin,” Stem Cells and Development, vol. 19, no. 4, pp. 469–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Hynes, D. Menichanin, R. Bright et al., “Induced pluripotent stem cells: a new frontier for stem cells in dentistry,” Journal of Dental Research, vol. 94, no. 11, pp. 1508–1515, 2015. View at Publisher · View at Google Scholar
  13. T. C. Srijaya, P. J. Pradeep, R. B. Zain, S. Musa, N. H. Abu Kasim, and V. Govindasamy, “The promise of human induced pluripotent stem cells in dental research,” Stem Cells International, vol. 2012, Article ID 423868, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Yoo, H.-J. Na, D.-S. Lee et al., “Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases,” Biomaterials, vol. 34, no. 33, pp. 8149–8160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Chen, M. Lin, J. J. Foxe et al., “Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts,” PLoS ONE, vol. 8, no. 10, Article ID e75682, 2013. View at Publisher · View at Google Scholar
  16. H. C. Slavkin, “The human genome, implications for oral health and diseases, and dental education,” Journal of Dental Education, vol. 65, no. 5, pp. 463–479, 2001. View at Google Scholar · View at Scopus
  17. J. B. Gurdon, “The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles,” Journal of Embryology and Experimental Morphology, vol. 10, pp. 622–640, 1962. View at Google Scholar · View at Scopus
  18. I. Wilmut, A. E. Schnieke, J. McWhir, A. J. Kind, and K. H. S. Campbell, “Viable offspring derived from fetal and adult mammalian cells,” Nature, vol. 385, no. 6619, pp. 810–813, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Tada, Y. Takahama, K. Abe, N. Nakatsuji, and T. Tada, “Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells,” Current Biology, vol. 11, no. 19, pp. 1553–1558, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Schneuwly, R. Klemenz, and W. J. Gehring, “Redesigning the body plan of Drosophila by ectopic expression of the homoeotic gene Antennapedia,” Nature, vol. 325, no. 6107, pp. 816–818, 1987. View at Publisher · View at Google Scholar · View at Scopus
  21. R. L. Davis, H. Weintraub, and A. B. Lassar, “Expression of a single transfected cDNA converts fibroblasts to myoblasts,” Cell, vol. 51, no. 6, pp. 987–1000, 1987. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Evans and M. H. Kaufman, “Establishment in culture of pluripotential cells from mouse embryos,” Nature, vol. 292, no. 5819, pp. 154–156, 1981. View at Publisher · View at Google Scholar · View at Scopus
  23. A. G. Smith, J. K. Heath, D. D. Donaldson et al., “Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides,” Nature, vol. 336, no. 6200, pp. 688–690, 1988. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Publisher · View at Google Scholar
  25. S. Nayak and R. W. Herzog, “Progress and prospects: immune responses to viral vectors,” Gene Therapy, vol. 17, no. 3, pp. 295–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Aoi, K. Yae, M. Nakagawa et al., “Generation of pluripotent stem cells from adult mouse liver and stomach cells,” Science, vol. 321, no. 5889, pp. 699–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka, and S. Yamanaka, “Generation of mouse induced pluripotent stem cells without viral vectors,” Science, vol. 322, no. 5903, pp. 949–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Warren, P. D. Manos, T. Ahfeldt et al., “Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA,” Cell Stem Cell, vol. 7, no. 5, pp. 618–630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Kim, C.-H. Kim, J.-I. Moon et al., “Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins,” Cell Stem Cell, vol. 4, no. 6, pp. 472–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Fusaki, H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa, “Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome,” Proceedings of the Japan Academy. Series B: Physical and Biological Sciences, vol. 85, no. 8, pp. 348–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Miyoshi, H. Ishii, H. Nagano et al., “Reprogramming of mouse and human cells to pluripotency using mature microRNAs,” Cell Stem Cell, vol. 8, no. 6, pp. 633–638, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Tsukiyama, R. Asano, T. Kawaguchi et al., “Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system,” Genes to Cells, vol. 16, no. 7, pp. 815–825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Cao, W. Deng, R. Qu et al., “Non-viral co-delivery of the four yamanaka factors for generation of human induced pluripotent stem cells via calcium phosphate nanocomposite particles,” Advanced Functional Materials, vol. 23, no. 43, pp. 5403–5411, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Montserrat, E. Garreta, F. González et al., “Simple generation of human induced pluripotent stem cells using poly-β-amino esters as the non-viral gene delivery system,” The Journal of Biological Chemistry, vol. 286, no. 14, pp. 12417–12428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Lee, J.-H. Kim, H. J. Lee et al., “The generation of iPS cells using non-viral magnetic nanoparticle based transfection,” Biomaterials, vol. 32, no. 28, pp. 6683–6691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Zhu, J. Li, H. Lai, C. Yang, C. Guo, and C. Wang, “Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 5837–5847, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-D. Sohn, I. Somasuntharam, P.-L. Che et al., “Induction of pluripotency in bone marrow mononuclear cells via polyketal nanoparticle-mediated delivery of mature microRNAs,” Biomaterials, vol. 34, no. 17, pp. 4235–4241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Khan, K. Narayanan, H. Lu et al., “Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector,” Biomaterials, vol. 34, no. 21, pp. 5336–5343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Baek, X. Quan, S. Kim, C. Lengner, J.-K. Park, and J. Kim, “Electromagnetic fields mediate efficient cell reprogramming into a pluripotent state,” ACS Nano, vol. 8, no. 10, pp. 10125–10138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Yoo, J. Kim, S. Baek, Y. Park, H. Im, and J. Kim, “Cell reprogramming into the pluripotent state using graphene based substrates,” Biomaterials, vol. 35, no. 29, pp. 8321–8329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Cordie, T. Harkness, X. Jing et al., “Nanofibrous electrospun polymers for reprogramming human cells,” Cellular and Molecular Bioengineering, vol. 7, no. 3, pp. 379–393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Miyoshi, D. Tsuji, K. Kudoh et al., “Generation of human induced pluripotent stem cells from oral mucosa,” Journal of Bioscience and Bioengineering, vol. 110, no. 3, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Egusa, K. Okita, H. Kayashima et al., “Gingival fibroblasts as a promising source of induced pluripotent stem cells,” PloS one, vol. 5, no. 9, Article ID e12743, 2010. View at Google Scholar · View at Scopus
  44. O. Bar-Nur, H. A. Russ, S. Efrat, and N. Benvenisty, “Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells,” Cell Stem Cell, vol. 9, no. 1, pp. 17–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Nashun, P. W. Hill, and P. Hajkova, “Reprogramming of cell fate: epigenetic memory and the erasure of memories past,” The EMBO Journal, vol. 34, no. 10, pp. 1296–1308, 2015. View at Publisher · View at Google Scholar
  46. Y.-C. Chang, W.-C. Li, N.-F. Twu et al., “Induction of dental pulp-derived induced pluripotent stem cells in the absence of c-Myc for differentiation into neuron-like cells,” Journal of the Chinese Medical Association, vol. 77, no. 12, pp. 618–625, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. I.-H. Park, N. Arora, H. Huo et al., “Disease-specific induced pluripotent stem cells,” Cell, vol. 134, no. 5, pp. 877–886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Raab, M. Klingenstein, S. Liebau, and L. Linta, “A comparative view on human somatic cell sources for iPSC generation,” Stem Cells International, vol. 2014, Article ID 768391, 12 pages, 2014. View at Publisher · View at Google Scholar
  49. S. Nori, Y. Okada, S. Nishimura et al., “Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition,” Stem Cell Reports, vol. 4, no. 3, pp. 360–373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. Q. Zhao, C. A. Gregory, R. H. Lee et al., “MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 2, pp. 530–535, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. G. A. Erickson, S. R. Bolin, and J. G. Landgraf, “Viral contamination of fetal bovine serum used for tissue culture: risks and concerns,” Developments in Biological Standardization, vol. 75, pp. 173–175, 1991. View at Google Scholar · View at Scopus
  52. T. Takeda-Kawaguchi, K. Sugiyama, S. Chikusa et al., “Derivation of iPSCs after culture of human dental pulp cells under defined conditions,” PLoS ONE, vol. 9, no. 12, Article ID e115392, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Gandia, A. N. A. Armiñan, J. M. García-Verdugo et al., “Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction,” STEM CELLS, vol. 26, no. 3, pp. 638–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. I. V. Nosrat, J. Widenfalk, L. Olson, and C. A. Nosrat, “Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury,” Developmental Biology, vol. 238, no. 1, pp. 120–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. R. D'Aquino, G. Papaccio, G. Laino, and A. Graziano, “Dental pulp stem cells: a promising tool for bone regeneration,” Stem Cell Reviews, vol. 4, no. 1, pp. 21–26, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Rizk and A. B. M. Rabie, “Human dental pulp stem cells expressing transforming growth factor β3 transgene for cartilage-like tissue engineering,” Cytotherapy, vol. 15, no. 6, pp. 712–725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Oda, Y. Yoshimura, H. Ohnishi et al., “Induction of pluripotent stem cells from human third molar mesenchymal stromal cells,” The Journal of Biological Chemistry, vol. 285, no. 38, pp. 29270–29278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Wang, Z. Tang, I.-H. Park et al., “Induced pluripotent stem cells for neural tissue engineering,” Biomaterials, vol. 32, no. 22, pp. 5023–5032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Denham and M. Dottori, “Neural differentiation of induced pluripotent stem cells,” Methods in Molecular Biology, vol. 793, pp. 99–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Bhattacharjee, E. Schultz-Thater, E. Trella et al., “The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials,” Biomaterials, vol. 34, no. 33, pp. 8161–8171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. K.-D. Choi, J. Yu, K. Smuga-Otto et al., “Hematopoietic and endothelial differentiation of human induced pluripotent stem cells,” STEM CELLS, vol. 27, no. 3, pp. 559–567, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. A. J. Rufaihah, N. F. Huang, S. Jamé et al., “Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. e72–e79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. M. P. White, A. J. Rufaihah, L. Liu et al., “Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells,” Stem Cells, vol. 31, no. 1, pp. 92–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Wen, F. Wang, W. Zhang et al., “Application of induced pluripotent stem cells in generation of a tissue-engineered tooth-like structure,” Tissue Engineering Part: A, vol. 18, no. 15-16, pp. 1677–1685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Otsu, M. Kumakami-Sakano, N. Fujiwara et al., “Stem cell sources for tooth regeneration: current status and future prospects,” Frontiers in Physiology, vol. 5, article 36, 2014. View at Publisher · View at Google Scholar · View at Scopus